Novavax to Showcase Innovations at the Jefferies London Healthcare Conference 2025 Novavax, Inc. will participate in the Jefferies London Healthcare Conference on November 19, 2025, discussing its advancements in vaccine technology.

Novavax to Showcase Innovations at the Jefferies London Healthcare Conference 2025 #London #United_Kingdom #Healthcare_Conference #Novavax #Vaccine_Technology

Anixa Biosciences Advances Breast Cancer Vaccine with New Patent Allowance Notification Anixa Biosciences has received a significant patent allowance for its innovative breast cancer vaccine technology, leveraging unique immunogenic compositions for preventative cancer strategies.

Anixa Biosciences Advances Breast Cancer Vaccine with New Patent Allowance Notification #United_States #Anixa_Biosciences #San_Jose #Breast_Cancer #Vaccine_Technology